“These findings can inform diagnosis, treatment and care of stroke among patients with COVID-19,” one researcher said. 

The 61-year-old cardiologist was piloting the plane when it crashed. 

Researchers tracked 29 years of data, uncovering a mix of good news and concerning trends. 

Songling Xuemaikang capsules compare favorably with losartan, potentially providing specialists with a new treatment option. 

The use of these devices when treating certain high-risk patients is still recommended.  

Same-day discharge was associated with a 15% reduction in healthcare costs. 

The team hopes its efforts can improve the way we predict a patient's risk of heart attack or stroke. 

Shortness of breath, dizziness, increased blood pressure and chest pain were among the most commonly reported issues.

The new analysis focused on in-hospital, 30-day and long-term outcomes. 

The findings back long-held beliefs that wasteful spending on healthcare is tied, in part, to inappropriate decision making, researchers explained in JAMA Health Forum.